ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 285 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $459,207 | -13.2% | 17,414 | 0.0% | 0.28% | -14.2% |
| Q1 2024 | $528,863 | +8.1% | 17,414 | 0.0% | 0.33% | +0.6% |
| Q4 2023 | $489,159 | +4.8% | 17,414 | 0.0% | 0.33% | -5.2% |
| Q3 2023 | $466,869 | -12.8% | 17,414 | 0.0% | 0.35% | -13.0% |
| Q2 2023 | $535,306 | -22.2% | 17,414 | 0.0% | 0.40% | -32.2% |
| Q4 2022 | $688,201 | -1.7% | 17,414 | 0.0% | 0.59% | -10.3% |
| Q3 2022 | $700,000 | -4.4% | 17,414 | 0.0% | 0.66% | -1.5% |
| Q2 2022 | $732,000 | +8.0% | 17,414 | 0.0% | 0.67% | +19.3% |
| Q1 2022 | $678,000 | +42.4% | 17,414 | +45.8% | 0.56% | +48.1% |
| Q4 2021 | $476,000 | – | 11,942 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $263,446,000 | 59.92% |
| Memorial Sloan Kettering Cancer Center | 1,128,255 | $43,957,000 | 50.90% |
| Vantage Consulting Group Inc | 2,727,854 | $106,277,000 | 41.47% |
| Indie Asset Partners, LLC | 756,874 | $29,488,000 | 22.15% |
| Overbrook Management Corp | 723,250 | $28,178,000 | 6.25% |
| Brown University | 621,759 | $24,224,000 | 5.93% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $8,527,000 | 3.82% |
| Lagoda Investment Management, L.P. | 141,560 | $5,515,000 | 2.97% |
| Greytown Advisors Inc. | 131,143 | $5,109,000 | 2.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,025,610 | $78,918,000 | 2.41% |